|
Asian Journal of Andrology (2012) 14, 465-475; doi:10.1038/aja.2012.20; published online 23 April 2012
Why are epididymal tumours so rare?
Ching-Hei Yeung1,2, Kai Wang1,3 and Trevor G Cooper1,2
1 Shandong Stem Cell Engineering and Technology Research Centre, YuHuangDing Hospital, Yantai 26400, China
2 Centre of Reproductive Medicine and Andrology of the University Clinic, Münster, D48149, Germany
3 Central Laboratory, YuHuangDing Hospital, Yantai 26400, China
Correspondence: Dr TG Cooper, (ctrevorg@live.hk)
Received 6 January 2012; Revised 19 January 2012; Accepted 20 January 2012
Advance online publication 23 April 2012.
| Abstract |
Epididymal tumour incidence is at most 0.03% of all male cancers. It is an enigma why the human epididymis does not often succumb to cancer, when it expresses markers of stem and cancer cells, and constitutively expresses oncogenes, pro-proliferative and pro-angiogenic factors that allow tumour cells to escape immunosurveillance in cancer-prone tissues. The privileged position of the human epididymis in evading tumourigenicity is reflected in transgenic mouse models in which induction of tumours in other organs is not accompanied by epididymal neoplasia. The epididymis appears to: (i) prevent tumour initiation (it probably lacks stem cells and has strong anti-oxidative mechanisms, active tumour suppressors and inactive oncogene products); (ii) foster tumour monitoring and destruction (by strong immuno-surveillance and -eradication, and cellular senescence); (iii) avert proliferation and angiogenesis (with persistent tight junctions, the presence of anti-angiogenic factors and misplaced pro-angiogenic factors), which together (iv) promote dormancy and restrict dividing cells to hyperplasia. Epididymal cells may be rendered non-responsive to oncogenic stimuli by the constitutive expression of factors generally inducible in tumours, and resistant to the normal epididymal environment, which mimics that of a tumour niche promoting tumour growth. The threshold for tumour initiation may thus be higher in the epididymis than in other organs. Several anti-tumour mechanisms are those that maintain spermatozoa quiescent and immunologically silent, so the low incidence of cancer in the epididymis may be a consequence of its role in sperm maturation and storage. Understanding these mechanisms may throw light on cancer prevention and therapy in general.
Keywords: anti-oxidation; cell proliferation; metabolic reprogramming; tumour dormancy; tumour suppression |
|
